Now showing items 1-3 of 3

    • Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. 

      Cooke, R; Jones, ME; Cunningham, D; Falk, SJ; Gilson, D; Hancock, BW; Harris, SJ; Horwich, A; Hoskin, PJ; Illidge, T; Linch, DC; Lister, TA; Lucraft, HH; Radford, JA; Stevens, AM; Syndikus, I; Williams, MV; England and Wales Hodgkin Lymphoma Follow-up Group; Swerdlow, AJ (2013-06)
      Background Women treated with supradiaphragmatic radiotherapy (sRT) for Hodgkin lymphoma (HL) at young ages have a substantially increased breast cancer risk. Little is known about how menarcheal and reproductive factors ...
    • Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. 

      Sud, A; Jones, ME; Broggio, J; Loveday, C; Torr, B; Garrett, A; Nicol, DL; Jhanji, S; Boyce, SA; Gronthoud, F; Ward, P; Handy, JM; Yousaf, N; Larkin, J; Suh, Y-E; Scott, S; Pharoah, PDP; Swanton, C; Abbosh, C; Williams, M; Lyratzopoulos, G; Houlston, R; Turnbull, C (2020-08)
      Background Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of cancers during delay will impact on patients' long-term ...
    • Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. 

      Sud, A; Torr, B; Jones, ME; Broggio, J; Scott, S; Loveday, C; Garrett, A; Gronthoud, F; Nicol, DL; Jhanji, S; Boyce, SA; Williams, M; Riboli, E; Muller, DC; Kipps, E; Larkin, J; Navani, N; Swanton, C; Lyratzopoulos, G; McFerran, E; Lawler, M; Houlston, R; Turnbull, C (2020-08)
      Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%. We aimed to examine the impact of different scenarios ...